Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-UK for sale

Fri, 09th Jul 2021 09:59

Welcome to the home for real-time coverage of markets brought to you by Reuters stocks
reporters.

UK FOR SALE (0859 GMT)

There's been a burst of M&A activity in the UK in recent weeks, with Spire Healthcare
, Morrison Supermarkets and Vectura all being targeted. But then there
were tons of other private deals as well throughout the year.

The value of UK Plc acquisitions (pending and completed ones) has soared to $176 billion so
far in 2021, nearly double of the same period in 2020, according to Refinitiv data.

What's more, British blue chip stocks are the only ones among developed market peers to have
not scaled back pre-pandemic peak. They are one of the cheapest out there on a forward
price-to-earnings basis. Let's not forget, UK also tops the charts on dividend pays.

Those deals are a welcome relief for UK stock markets, which have heavily underperformed
European and U.S. stocks since the Brexit referendum.

(Thyagaraju Adinarayan)

*****

TRAVEL STOCKS BOOST EUROPE AT OPEN (0723 GMT)

Europe's STOXX 600 rises 0.8% as bond markets calm down and some of the cyclical
names bounce after yesterday's brutal selloff.

Travel stocks were top sectoral gainers (+2%) as the UK further relaxed quarantine rules. In
the coming weeks, it's set to scrap quarantine for fully-vaccinated arrivals from other
countries.

Bond proxy sectors telecom and utilities were among the underperformers after recent rally.

Among single stocks, Vectura jumps 12.5% after cigarette maker Philip Morris outbid PE firm
Carlyle to buy the British pharma company.

(Thyagaraju Adinarayan)

*****

YOU NEED TO CALM DOWN... (0651 GMT)

In a week that's seen U.S. Treasury yields dive as much as 20 basis points in three sessions
and European stocks suffer one of their worst days in two months, perhaps investors are heeding
the words from Taylor Swift's "You need to calm down."

Stock futures point to a brighter start for Europe, where indices were a sea of red just a
day ago. U.S. 10-year Treasury yields are up 5 bps -- a sign that the relentless push into
safe-haven debt markets of the last few days is abating.

Okay, so Asian shares are languishing at two-month lows on concerns that the spread of Delta
variants will hurt world growth. But compared to the last few sessions, a sense of calm finally
appears to be taking hold as the week draws to an end.

With the idea that reflation is dead or at least taking a break for now and surging variants
of COVID-19 cast a shadow over the global economic recovery, a rethink has clearly taken place
among investors.

Thursday's decision by the European Central Bank to set a new 2% inflation target, versus a
previous below but close to 2%, left markets unfazed but was generally seen as pointing to an
even longer period of central bank stimulus.

For some, the scale of the fast and furious moves in bond markets have gone too far and
reflect a shake-out in positioning rather than a real shift in underlying economic conditions.
Time will tell.

The Biden administration is set as early as Friday to add more than 10 Chinese companies to
its economic blacklist over alleged human rights abuses and high-tech surveillance in Xinjiang,
two sources told Reuters.

Any signs of resurgent tensions between the world's two biggest economies could of course
quickly send investors back into safe-haven assets.

Key developments that should provide more direction to markets on Friday:

- China's factory gate inflation slows

- Morgan Stanley faces data breach, corporate client info stolen in vendor hack

- UK economy grew by slower-than expected 0.8% in May

- UK May industrial output up 0.8% in m/m

- Canada June unemployment rate.

- ECB Andrea Enria participated in panel discussion

- Fitch Ratings review on Russia, Lithuania

- G20 kick off two-day summit in Venice, Italy.

(Dhara Ranasinghe)

*****

MORNING CALL: IT'S SETTLING DOWN A BIT

European stocks are set to edge higher after one of their worst days in 2021 as the rally in
U.S. Treasuries this week cools. Volatility has also receded with the Wall Street 'fear guage'
VIX closing at 19 points after exceeding 20 on Thursday.

Those moves have killed the momentum in reflation trade and some analysts believe we've
probably alread seen the best of it. The global spread of the Delta virus variant has spooked
investor confidence across the world.

"Yesterday’s continued slide in bond yields, along with a sharp fall in stock markets,
appears to be painting a narrative that the reflation trade is dead or dying," says Michael
Hewson, chief market analyst at CMC Markets UK.

In the corporate world, Airbus said its jet deliveries rose 52% in the first-half.

Another interesting story is how UK supermarkets are super-stretched by soaring demand for
beer, soft drinks, salads and barbecue food as England supporters prepare for Sunday's Euro 2020
final.

(Thyagaraju Adinarayan)

*****

More News
19 Apr 2018 12:53

hVIVO CEO Steps Down In Favour Of Executive Chair As Loss Narrows

LONDON (Alliance News) - Clinical development and drug discovery business hVIVO PLC said Thursday its loss narrowed in 2017 as Chief Executive Kym Denny stepped aside for Executive Chairman Trevor

Read more
3 Apr 2018 08:41

EUROPE RESEARCH ROUNDUP-Aevis Victoria, Martela Oyj, Mediaset

April 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Aevis Victoria, Martela Oyj and Mediaset, on Tuesday. HIGHLIGHTS * Aevis SA

Read more
23 Mar 2018 18:23

DIRECTOR DEALINGS: Vectura Non-Executive Juliet Thompson Buys Shares

LONDON (Alliance News) - Vectura Group PLC said Friday Non-Executive Director Juliet Thompson bought shares worth GBP36,284 in the pharmaceutical company after

Read more
22 Mar 2018 16:16

DIRECTOR DEALINGS: Vectura Chairman, Non-Exec Director Buy Shares

LONDON (Alliance News) - Vectura Group PLC said on Thursday that two directors bought shares in the company on Wednesday.Chairman Bruno Angelici purchased 75,000 shares

Read more
21 Mar 2018 08:52

Vectura Delivers "Good" 2017 Results Despite Advair Disappointment

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC said Wednesday it delivered a "good" set of 2017 results with underlying profit and revenue growth to

Read more
21 Mar 2018 08:31

UPDATE 1-UK's Vectura posts wider 2017 loss, revenue rise

March 21 (Reuters) - British drugmaker Vectura reported a worse-than-expected pretax loss for the full year on Wednesday, dragged by lower royalties and higher costs related to the SkyePharma for

Read more
21 Mar 2018 07:47

UPDATE 1-UK Stocks-Factors to watch on March 21

March 21 (Reuters) - Britain's FTSE 100 index is seen opening up 13 points on Wednesday, according to financial bookmakers, with futures 0.26 pct higher ahead of the cash

Read more
21 Mar 2018 07:40

Drugmaker Vectura's 2017 revenue rises 17.2 pct

March 21 (Reuters) - British drugmaker Vectura reported a 17.2 percent rise in 2017 revenue on Wednesday, aided by higher demand for its asthma products Flutiform and Ultibro. The company,

Read more
20 Mar 2018 13:21

Legal & General Increases Vectura Stake To 3.7% From Below 3% (ALLISS)

LONDON (Alliance News) - Vectura Group PLC said Tuesday FTSE 100-listed insurer and asset manager Legal & General Group PLC increased its stake in the pharmaceutical firm

Read more
14 Mar 2018 16:20

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 15 March Old MutualFull Year ResultsPhoenix GroupFull Year GroupFull 16

Read more
12 Mar 2018 10:43

WINNERS & LOSERS SUMMARY: Vectura And Hikma Hurt By US FDA Ruling

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------easyJet, up 2.3% at on

Read more
12 Mar 2018 09:43

FTSE 100 lags Europe on miners and energy, Just Eat goes cold

(For a live blog on European stocks, type LIVE/ in an Eikon news window) * FTSE 100 up 0.1 pct * Just Eat hit by DB downgrade * Vectura, Hikma hit by delay to Advair GKN up 12

Read more
16 Feb 2017 07:49

Vectura Hits GBP9 Million Royalty Cap Under Skyepharma Legacy Deal

Read more
16 Feb 2017 07:06

Vectura's GSK royalties agreements firing on all cylinders

(ShareCast News) - Vectura Group hit its royalty cap on sales of GlaxoSmithKline´s Ellipta range of products in 2016, one year ahead of forecasts. The cap was equivalent to £9.0m. The inhaled airways disease-focused business was also set to record £5.4m of 2016 revenues under a separate single digi

Read more
8 Feb 2017 13:49

UPDATE 1-Weak pound buoys GSK but drugmaker warns on 2017 generic threat

* 2017 core EPS seen flat-lower if mid-year generic Advair * Current exchange rates would lift 2017 sterling EPS 9 pct * Q4 2016 core EPS 26.1 pence vs consensus forecast 25.0p (Adds CEO comments, shares, background on new CEO) By Ben Hirschler LONDON, Feb 8 (Reuters) -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.